The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia

1 - 2 December 2020

Marriott Grand Hotel, Moscow, Russia

Confirmed speakers:

Dmitry Schekin, Deputy Head of the Division for Coordination of Work on Pharmaceutical Drugs and Medical Devices Circulation, Department for Technical Regulation and Accreditation, Eurasian Economic Commission
Dmitry Schekin

Deputy Head of the Division for Coordination of Work on Pharmaceutical Drugs and Medical Devices Circulation, Department for Technical Regulation and Accreditation

Eurasian Economic Commission

Sergey Dubrovin, Site Relationship Partner (Director), Russia and Belarus, Pfizer
Sergey Dubrovin

Site Relationship Partner (Director), Russia and Belarus

Pfizer

Vladimir Bulatov, Chief Scientific Officer, Novartis Pharma, Russia
Vladimir Bulatov

Chief Scientific Officer

Novartis Pharma, Russia

Tatiana Goldina, Data Generation & Scientific Communication Lead, Medical Affairs, Sanofi
Tatiana Goldina

Data Generation & Scientific Communication Lead, Medical Affairs

Sanofi

Alina Mustafina, Deputy Head of the Division on Medical Devices Expertise and Safety Monitoring, National Institute of Quality of Roszdravnadzor
Alina Mustafina

Deputy Head of the Division on Medical Devices Expertise and Safety Monitoring

National Institute of Quality of Roszdravnadzor

Maria Leer, Head of Medical Projects Group, Takeda
Maria Leer

Head of Medical Projects Group

Takeda

Julia Trakhtenberg, Medical director, IPHARMA
Julia Trakhtenberg

Medical director

IPHARMA

KEY TOPICS & FEATURES IN 2020:

o   The current status of the clinical trials market: what are the latest trends in Russia and globally?

o   Clinical trials during the Covid-19 pandemic: practical experiences, challenges and solutions found

o   Clinical trials in the Eurasian Union - registration practices and common rules in action

o   Acceleration of digitalisation in clinical trials: AI, remote monitoring, electronic registers, access to data and data safety

o   RWE - globally and in Russia: RWE as a key tool for the federal project “Digital technologies”

o   Live Interviews with sponsors and research & investigators centres

Why to attend the Clinical Trials in Russia Forum in 2020?

adamsmith 14october2018 049

Insights from 40+ experts: regulators, representatives of international and Russian pharmaceutical producers, CROs and investigators

adamsmith 13october2018 206

2-day information-rich programme that includes insightful presentations from leading sector players, interactive debates and round tables

adamsmith 13october2018 086

Unrivalled networking opportunities with 150+ attendees from such companies as AstraZeneca, Pfizer, Novartis, Bayer, Biocad, R-Pharm and many more

FEEDBACK FROM ATTENDEES

Unique opportunity for all the clinical trials sector players to meet and discuss the most burning issues.

Tatiana Minakova,

Associate Director, Clinical Monitoring, Syneos Health

The forum brings together representatives of all stakeholder groups involved in clinical trials – sponsors, CROs, regulators and investigators for a constructive dialogue aimed at improving all future processes.

Julia Semenova,

Pharma Development Unit Head, Novartis Russia

Very good overview of a large number of clinical trial topics and the specifics of the Russian market.

Henryette Schatt,

JDirector eCOA Business Development, ERT (Switzerland)

Very interesting insight into the latest developments in the Russian market.

Stefanie Rau,

Clinical Trials and Pharmacovigilance Manager Europe, MUCOS Pharma (Germany)


Sponsored by:

Supporting organisations & media